nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA2—osteoporosis	0.321	1	CbGaD
Celecoxib—CA14—Zoledronate—osteoporosis	0.105	0.249	CbGbCtD
Celecoxib—CA12—Zoledronate—osteoporosis	0.0747	0.177	CbGbCtD
Celecoxib—CA2—Zoledronate—osteoporosis	0.0604	0.143	CbGbCtD
Celecoxib—PTGS2—Risedronate—osteoporosis	0.0487	0.115	CbGbCtD
Celecoxib—ABCC4—Conjugated Estrogens—osteoporosis	0.0297	0.0704	CbGbCtD
Celecoxib—ALB—Estropipate—osteoporosis	0.0233	0.0552	CbGbCtD
Celecoxib—CYP2C9—Estropipate—osteoporosis	0.0125	0.0297	CbGbCtD
Celecoxib—ALB—Estradiol—osteoporosis	0.00966	0.0229	CbGbCtD
Celecoxib—CYP3A4—Estropipate—osteoporosis	0.00729	0.0173	CbGbCtD
Celecoxib—CYP3A4—Calcitriol—osteoporosis	0.00729	0.0173	CbGbCtD
Celecoxib—CYP2C9—Cholecalciferol—osteoporosis	0.00646	0.0153	CbGbCtD
Celecoxib—CYP2D6—Cholecalciferol—osteoporosis	0.00591	0.014	CbGbCtD
Celecoxib—CYP3A4—Ergocalciferol—osteoporosis	0.00583	0.0138	CbGbCtD
Celecoxib—CYP2C9—Estradiol—osteoporosis	0.00521	0.0123	CbGbCtD
Celecoxib—CYP3A4—Raloxifene—osteoporosis	0.00487	0.0115	CbGbCtD
Celecoxib—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0047	0.0111	CbGbCtD
Celecoxib—CYP3A4—Cholecalciferol—osteoporosis	0.00376	0.0089	CbGbCtD
Celecoxib—CYP3A4—Conjugated Estrogens—osteoporosis	0.00345	0.00818	CbGbCtD
Celecoxib—CYP3A4—Estradiol—osteoporosis	0.00303	0.00718	CbGbCtD
Celecoxib—ORM1—vertebral column—osteoporosis	0.000851	0.243	CbGeAlD
Celecoxib—CA2—periosteum—osteoporosis	0.000664	0.189	CbGeAlD
Celecoxib—PTGS2—periosteum—osteoporosis	0.000491	0.14	CbGeAlD
Celecoxib—PDPK1—uterus—osteoporosis	0.000436	0.124	CbGeAlD
Celecoxib—MAPK14—uterus—osteoporosis	0.000233	0.0665	CbGeAlD
Celecoxib—MAPK14—bone marrow—osteoporosis	0.000198	0.0564	CbGeAlD
Celecoxib—ABCC4—uterus—osteoporosis	0.000119	0.034	CbGeAlD
Celecoxib—ORM1—bone marrow—osteoporosis	0.000119	0.034	CbGeAlD
Celecoxib—ABCC4—bone marrow—osteoporosis	0.000101	0.0288	CbGeAlD
Celecoxib—CA4—bone marrow—osteoporosis	9.3e-05	0.0265	CbGeAlD
Celecoxib—CA2—bone marrow—osteoporosis	7.71e-05	0.022	CbGeAlD
Celecoxib—PTGS2—uterus—osteoporosis	6.71e-05	0.0191	CbGeAlD
Celecoxib—Palpitations—Conjugated Estrogens—osteoporosis	6.57e-05	0.000424	CcSEcCtD
Celecoxib—Insomnia—Risedronate—osteoporosis	6.56e-05	0.000424	CcSEcCtD
Celecoxib—Anxiety—Zoledronate—osteoporosis	6.55e-05	0.000423	CcSEcCtD
Celecoxib—Loss of consciousness—Conjugated Estrogens—osteoporosis	6.53e-05	0.000422	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	6.53e-05	0.000421	CcSEcCtD
Celecoxib—Paraesthesia—Risedronate—osteoporosis	6.51e-05	0.000421	CcSEcCtD
Celecoxib—Pruritus—Estropipate—osteoporosis	6.49e-05	0.000419	CcSEcCtD
Celecoxib—Asthenia—Alendronate—osteoporosis	6.49e-05	0.000419	CcSEcCtD
Celecoxib—Hypersensitivity—Ibandronate—osteoporosis	6.49e-05	0.000419	CcSEcCtD
Celecoxib—Cough—Conjugated Estrogens—osteoporosis	6.49e-05	0.000419	CcSEcCtD
Celecoxib—Dyspnoea—Risedronate—osteoporosis	6.47e-05	0.000418	CcSEcCtD
Celecoxib—Erythema multiforme—Estradiol—osteoporosis	6.46e-05	0.000417	CcSEcCtD
Celecoxib—Dry mouth—Zoledronate—osteoporosis	6.43e-05	0.000415	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	6.42e-05	0.000415	CcSEcCtD
Celecoxib—Fatigue—Ethinyl Estradiol—osteoporosis	6.42e-05	0.000414	CcSEcCtD
Celecoxib—Pruritus—Alendronate—osteoporosis	6.4e-05	0.000413	CcSEcCtD
Celecoxib—Dyspepsia—Risedronate—osteoporosis	6.39e-05	0.000412	CcSEcCtD
Celecoxib—Eye disorder—Estradiol—osteoporosis	6.39e-05	0.000412	CcSEcCtD
Celecoxib—Tinnitus—Estradiol—osteoporosis	6.37e-05	0.000411	CcSEcCtD
Celecoxib—Constipation—Ethinyl Estradiol—osteoporosis	6.36e-05	0.000411	CcSEcCtD
Celecoxib—Confusional state—Zoledronate—osteoporosis	6.35e-05	0.00041	CcSEcCtD
Celecoxib—Hypersensitivity—Calcitriol—osteoporosis	6.35e-05	0.00041	CcSEcCtD
Celecoxib—Flushing—Estradiol—osteoporosis	6.34e-05	0.00041	CcSEcCtD
Celecoxib—Cardiac disorder—Estradiol—osteoporosis	6.34e-05	0.00041	CcSEcCtD
Celecoxib—Chest pain—Conjugated Estrogens—osteoporosis	6.33e-05	0.000409	CcSEcCtD
Celecoxib—Myalgia—Conjugated Estrogens—osteoporosis	6.33e-05	0.000409	CcSEcCtD
Celecoxib—Arthralgia—Conjugated Estrogens—osteoporosis	6.33e-05	0.000409	CcSEcCtD
Celecoxib—Asthenia—Ibandronate—osteoporosis	6.32e-05	0.000408	CcSEcCtD
Celecoxib—Anxiety—Conjugated Estrogens—osteoporosis	6.31e-05	0.000407	CcSEcCtD
Celecoxib—Nausea—Etidronic acid—osteoporosis	6.3e-05	0.000407	CcSEcCtD
Celecoxib—Oedema—Zoledronate—osteoporosis	6.3e-05	0.000407	CcSEcCtD
Celecoxib—Anaphylactic shock—Zoledronate—osteoporosis	6.3e-05	0.000407	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	6.28e-05	0.000406	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Pamidronate—osteoporosis	6.28e-05	0.000406	CcSEcCtD
Celecoxib—Diarrhoea—Estropipate—osteoporosis	6.28e-05	0.000406	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Risedronate—osteoporosis	6.26e-05	0.000405	CcSEcCtD
Celecoxib—Infection—Zoledronate—osteoporosis	6.26e-05	0.000404	CcSEcCtD
Celecoxib—Fatigue—Risedronate—osteoporosis	6.25e-05	0.000404	CcSEcCtD
Celecoxib—Insomnia—Pamidronate—osteoporosis	6.24e-05	0.000403	CcSEcCtD
Celecoxib—Pruritus—Ibandronate—osteoporosis	6.23e-05	0.000402	CcSEcCtD
Celecoxib—Constipation—Risedronate—osteoporosis	6.2e-05	0.000401	CcSEcCtD
Celecoxib—Angiopathy—Estradiol—osteoporosis	6.2e-05	0.0004	CcSEcCtD
Celecoxib—Shock—Zoledronate—osteoporosis	6.2e-05	0.0004	CcSEcCtD
Celecoxib—Paraesthesia—Pamidronate—osteoporosis	6.19e-05	0.0004	CcSEcCtD
Celecoxib—Diarrhoea—Alendronate—osteoporosis	6.19e-05	0.0004	CcSEcCtD
Celecoxib—Asthenia—Calcitriol—osteoporosis	6.18e-05	0.000399	CcSEcCtD
Celecoxib—Nervous system disorder—Zoledronate—osteoporosis	6.18e-05	0.000399	CcSEcCtD
Celecoxib—Immune system disorder—Estradiol—osteoporosis	6.17e-05	0.000399	CcSEcCtD
Celecoxib—Thrombocytopenia—Zoledronate—osteoporosis	6.17e-05	0.000398	CcSEcCtD
Celecoxib—Mediastinal disorder—Estradiol—osteoporosis	6.16e-05	0.000398	CcSEcCtD
Celecoxib—Dyspnoea—Pamidronate—osteoporosis	6.15e-05	0.000397	CcSEcCtD
Celecoxib—Tachycardia—Zoledronate—osteoporosis	6.15e-05	0.000397	CcSEcCtD
Celecoxib—Feeling abnormal—Ethinyl Estradiol—osteoporosis	6.13e-05	0.000396	CcSEcCtD
Celecoxib—Somnolence—Pamidronate—osteoporosis	6.13e-05	0.000396	CcSEcCtD
Celecoxib—Skin disorder—Zoledronate—osteoporosis	6.12e-05	0.000395	CcSEcCtD
Celecoxib—Pruritus—Calcitriol—osteoporosis	6.1e-05	0.000394	CcSEcCtD
Celecoxib—Hyperhidrosis—Zoledronate—osteoporosis	6.09e-05	0.000393	CcSEcCtD
Celecoxib—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	6.08e-05	0.000393	CcSEcCtD
Celecoxib—Diarrhoea—Raloxifene—osteoporosis	6.08e-05	0.000393	CcSEcCtD
Celecoxib—Dyspepsia—Pamidronate—osteoporosis	6.07e-05	0.000392	CcSEcCtD
Celecoxib—Dizziness—Estropipate—osteoporosis	6.07e-05	0.000392	CcSEcCtD
Celecoxib—Anaphylactic shock—Conjugated Estrogens—osteoporosis	6.07e-05	0.000392	CcSEcCtD
Celecoxib—Oedema—Conjugated Estrogens—osteoporosis	6.07e-05	0.000392	CcSEcCtD
Celecoxib—Alopecia—Estradiol—osteoporosis	6.04e-05	0.00039	CcSEcCtD
Celecoxib—Infection—Conjugated Estrogens—osteoporosis	6.03e-05	0.000389	CcSEcCtD
Celecoxib—Diarrhoea—Ibandronate—osteoporosis	6.02e-05	0.000389	CcSEcCtD
Celecoxib—Anorexia—Zoledronate—osteoporosis	6e-05	0.000388	CcSEcCtD
Celecoxib—Decreased appetite—Pamidronate—osteoporosis	6e-05	0.000387	CcSEcCtD
Celecoxib—Mental disorder—Estradiol—osteoporosis	5.99e-05	0.000387	CcSEcCtD
Celecoxib—Dizziness—Alendronate—osteoporosis	5.98e-05	0.000386	CcSEcCtD
Celecoxib—Shock—Conjugated Estrogens—osteoporosis	5.97e-05	0.000385	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Pamidronate—osteoporosis	5.95e-05	0.000385	CcSEcCtD
Celecoxib—Nervous system disorder—Conjugated Estrogens—osteoporosis	5.95e-05	0.000384	CcSEcCtD
Celecoxib—Fatigue—Pamidronate—osteoporosis	5.95e-05	0.000384	CcSEcCtD
Celecoxib—Gastrointestinal pain—Risedronate—osteoporosis	5.93e-05	0.000383	CcSEcCtD
Celecoxib—Tachycardia—Conjugated Estrogens—osteoporosis	5.92e-05	0.000382	CcSEcCtD
Celecoxib—Urticaria—Ethinyl Estradiol—osteoporosis	5.91e-05	0.000382	CcSEcCtD
Celecoxib—Constipation—Pamidronate—osteoporosis	5.9e-05	0.000381	CcSEcCtD
Celecoxib—Diarrhoea—Calcitriol—osteoporosis	5.9e-05	0.000381	CcSEcCtD
Celecoxib—Skin disorder—Conjugated Estrogens—osteoporosis	5.89e-05	0.000381	CcSEcCtD
Celecoxib—Abdominal pain—Ethinyl Estradiol—osteoporosis	5.88e-05	0.00038	CcSEcCtD
Celecoxib—Body temperature increased—Ethinyl Estradiol—osteoporosis	5.88e-05	0.00038	CcSEcCtD
Celecoxib—Dizziness—Raloxifene—osteoporosis	5.88e-05	0.00038	CcSEcCtD
Celecoxib—Hyperhidrosis—Conjugated Estrogens—osteoporosis	5.86e-05	0.000379	CcSEcCtD
Celecoxib—Flatulence—Estradiol—osteoporosis	5.86e-05	0.000379	CcSEcCtD
Celecoxib—Tension—Estradiol—osteoporosis	5.84e-05	0.000377	CcSEcCtD
Celecoxib—Vomiting—Estropipate—osteoporosis	5.84e-05	0.000377	CcSEcCtD
Celecoxib—Dysgeusia—Estradiol—osteoporosis	5.83e-05	0.000376	CcSEcCtD
Celecoxib—Dizziness—Ibandronate—osteoporosis	5.82e-05	0.000376	CcSEcCtD
Celecoxib—Rash—Estropipate—osteoporosis	5.79e-05	0.000374	CcSEcCtD
Celecoxib—Dermatitis—Estropipate—osteoporosis	5.78e-05	0.000373	CcSEcCtD
Celecoxib—Anorexia—Conjugated Estrogens—osteoporosis	5.78e-05	0.000373	CcSEcCtD
Celecoxib—Nervousness—Estradiol—osteoporosis	5.78e-05	0.000373	CcSEcCtD
Celecoxib—Urticaria—Risedronate—osteoporosis	5.76e-05	0.000372	CcSEcCtD
Celecoxib—Back pain—Estradiol—osteoporosis	5.75e-05	0.000372	CcSEcCtD
Celecoxib—Headache—Estropipate—osteoporosis	5.75e-05	0.000371	CcSEcCtD
Celecoxib—Vomiting—Alendronate—osteoporosis	5.75e-05	0.000371	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Zoledronate—osteoporosis	5.74e-05	0.000371	CcSEcCtD
Celecoxib—Abdominal pain—Risedronate—osteoporosis	5.74e-05	0.00037	CcSEcCtD
Celecoxib—Body temperature increased—Risedronate—osteoporosis	5.74e-05	0.00037	CcSEcCtD
Celecoxib—Muscle spasms—Estradiol—osteoporosis	5.72e-05	0.000369	CcSEcCtD
Celecoxib—Rash—Alendronate—osteoporosis	5.7e-05	0.000368	CcSEcCtD
Celecoxib—Insomnia—Zoledronate—osteoporosis	5.7e-05	0.000368	CcSEcCtD
Celecoxib—Dermatitis—Alendronate—osteoporosis	5.7e-05	0.000368	CcSEcCtD
Celecoxib—PTGS2—bone marrow—osteoporosis	5.69e-05	0.0162	CbGeAlD
Celecoxib—Feeling abnormal—Pamidronate—osteoporosis	5.68e-05	0.000367	CcSEcCtD
Celecoxib—Headache—Alendronate—osteoporosis	5.66e-05	0.000366	CcSEcCtD
Celecoxib—Paraesthesia—Zoledronate—osteoporosis	5.66e-05	0.000365	CcSEcCtD
Celecoxib—Vomiting—Raloxifene—osteoporosis	5.65e-05	0.000365	CcSEcCtD
Celecoxib—Gastrointestinal pain—Pamidronate—osteoporosis	5.64e-05	0.000364	CcSEcCtD
Celecoxib—Dyspnoea—Zoledronate—osteoporosis	5.62e-05	0.000363	CcSEcCtD
Celecoxib—Rash—Raloxifene—osteoporosis	5.61e-05	0.000362	CcSEcCtD
Celecoxib—Dermatitis—Raloxifene—osteoporosis	5.6e-05	0.000362	CcSEcCtD
Celecoxib—Somnolence—Zoledronate—osteoporosis	5.6e-05	0.000362	CcSEcCtD
Celecoxib—Vomiting—Ibandronate—osteoporosis	5.6e-05	0.000361	CcSEcCtD
Celecoxib—Headache—Raloxifene—osteoporosis	5.57e-05	0.00036	CcSEcCtD
Celecoxib—Rash—Ibandronate—osteoporosis	5.55e-05	0.000358	CcSEcCtD
Celecoxib—Dermatitis—Ibandronate—osteoporosis	5.55e-05	0.000358	CcSEcCtD
Celecoxib—Dyspepsia—Zoledronate—osteoporosis	5.55e-05	0.000358	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	5.53e-05	0.000357	CcSEcCtD
Celecoxib—Headache—Ibandronate—osteoporosis	5.51e-05	0.000356	CcSEcCtD
Celecoxib—Insomnia—Conjugated Estrogens—osteoporosis	5.49e-05	0.000354	CcSEcCtD
Celecoxib—Hypersensitivity—Ethinyl Estradiol—osteoporosis	5.48e-05	0.000354	CcSEcCtD
Celecoxib—Vomiting—Calcitriol—osteoporosis	5.48e-05	0.000354	CcSEcCtD
Celecoxib—Decreased appetite—Zoledronate—osteoporosis	5.48e-05	0.000354	CcSEcCtD
Celecoxib—Nausea—Estropipate—osteoporosis	5.45e-05	0.000352	CcSEcCtD
Celecoxib—Abdominal pain—Pamidronate—osteoporosis	5.45e-05	0.000352	CcSEcCtD
Celecoxib—Body temperature increased—Pamidronate—osteoporosis	5.45e-05	0.000352	CcSEcCtD
Celecoxib—Paraesthesia—Conjugated Estrogens—osteoporosis	5.45e-05	0.000352	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Zoledronate—osteoporosis	5.44e-05	0.000351	CcSEcCtD
Celecoxib—Angioedema—Estradiol—osteoporosis	5.44e-05	0.000351	CcSEcCtD
Celecoxib—Rash—Calcitriol—osteoporosis	5.43e-05	0.000351	CcSEcCtD
Celecoxib—Fatigue—Zoledronate—osteoporosis	5.43e-05	0.000351	CcSEcCtD
Celecoxib—Dermatitis—Calcitriol—osteoporosis	5.43e-05	0.000351	CcSEcCtD
Celecoxib—Dyspnoea—Conjugated Estrogens—osteoporosis	5.41e-05	0.000349	CcSEcCtD
Celecoxib—Headache—Calcitriol—osteoporosis	5.4e-05	0.000349	CcSEcCtD
Celecoxib—Somnolence—Conjugated Estrogens—osteoporosis	5.39e-05	0.000348	CcSEcCtD
Celecoxib—Constipation—Zoledronate—osteoporosis	5.39e-05	0.000348	CcSEcCtD
Celecoxib—Nausea—Alendronate—osteoporosis	5.37e-05	0.000347	CcSEcCtD
Celecoxib—Hypersensitivity—Risedronate—osteoporosis	5.35e-05	0.000345	CcSEcCtD
Celecoxib—Vertigo—Estradiol—osteoporosis	5.34e-05	0.000345	CcSEcCtD
Celecoxib—Dyspepsia—Conjugated Estrogens—osteoporosis	5.34e-05	0.000345	CcSEcCtD
Celecoxib—Asthenia—Ethinyl Estradiol—osteoporosis	5.34e-05	0.000345	CcSEcCtD
Celecoxib—Syncope—Estradiol—osteoporosis	5.33e-05	0.000345	CcSEcCtD
Celecoxib—Nausea—Raloxifene—osteoporosis	5.28e-05	0.000341	CcSEcCtD
Celecoxib—Decreased appetite—Conjugated Estrogens—osteoporosis	5.27e-05	0.000341	CcSEcCtD
Celecoxib—Pruritus—Ethinyl Estradiol—osteoporosis	5.26e-05	0.00034	CcSEcCtD
Celecoxib—Palpitations—Estradiol—osteoporosis	5.26e-05	0.00034	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	5.24e-05	0.000338	CcSEcCtD
Celecoxib—Fatigue—Conjugated Estrogens—osteoporosis	5.23e-05	0.000338	CcSEcCtD
Celecoxib—Nausea—Ibandronate—osteoporosis	5.23e-05	0.000338	CcSEcCtD
Celecoxib—Loss of consciousness—Estradiol—osteoporosis	5.23e-05	0.000338	CcSEcCtD
Celecoxib—Asthenia—Risedronate—osteoporosis	5.21e-05	0.000336	CcSEcCtD
Celecoxib—Feeling abnormal—Zoledronate—osteoporosis	5.19e-05	0.000335	CcSEcCtD
Celecoxib—Cough—Estradiol—osteoporosis	5.19e-05	0.000335	CcSEcCtD
Celecoxib—Constipation—Conjugated Estrogens—osteoporosis	5.19e-05	0.000335	CcSEcCtD
Celecoxib—Gastrointestinal pain—Zoledronate—osteoporosis	5.15e-05	0.000333	CcSEcCtD
Celecoxib—Hypertension—Estradiol—osteoporosis	5.14e-05	0.000332	CcSEcCtD
Celecoxib—Pruritus—Risedronate—osteoporosis	5.13e-05	0.000332	CcSEcCtD
Celecoxib—Nausea—Calcitriol—osteoporosis	5.12e-05	0.000331	CcSEcCtD
Celecoxib—Diarrhoea—Ethinyl Estradiol—osteoporosis	5.09e-05	0.000329	CcSEcCtD
Celecoxib—Hypersensitivity—Pamidronate—osteoporosis	5.08e-05	0.000328	CcSEcCtD
Celecoxib—Chest pain—Estradiol—osteoporosis	5.06e-05	0.000327	CcSEcCtD
Celecoxib—Arthralgia—Estradiol—osteoporosis	5.06e-05	0.000327	CcSEcCtD
Celecoxib—Myalgia—Estradiol—osteoporosis	5.06e-05	0.000327	CcSEcCtD
Celecoxib—Anxiety—Estradiol—osteoporosis	5.05e-05	0.000326	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	5.03e-05	0.000325	CcSEcCtD
Celecoxib—Urticaria—Zoledronate—osteoporosis	5e-05	0.000323	CcSEcCtD
Celecoxib—Body temperature increased—Zoledronate—osteoporosis	4.98e-05	0.000322	CcSEcCtD
Celecoxib—Abdominal pain—Zoledronate—osteoporosis	4.98e-05	0.000322	CcSEcCtD
Celecoxib—Diarrhoea—Risedronate—osteoporosis	4.96e-05	0.000321	CcSEcCtD
Celecoxib—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	4.96e-05	0.00032	CcSEcCtD
Celecoxib—Dry mouth—Estradiol—osteoporosis	4.95e-05	0.00032	CcSEcCtD
Celecoxib—Asthenia—Pamidronate—osteoporosis	4.95e-05	0.00032	CcSEcCtD
Celecoxib—Dizziness—Ethinyl Estradiol—osteoporosis	4.92e-05	0.000318	CcSEcCtD
Celecoxib—Confusional state—Estradiol—osteoporosis	4.9e-05	0.000316	CcSEcCtD
Celecoxib—Pruritus—Pamidronate—osteoporosis	4.88e-05	0.000315	CcSEcCtD
Celecoxib—Oedema—Estradiol—osteoporosis	4.85e-05	0.000314	CcSEcCtD
Celecoxib—Anaphylactic shock—Estradiol—osteoporosis	4.85e-05	0.000314	CcSEcCtD
Celecoxib—Infection—Estradiol—osteoporosis	4.82e-05	0.000311	CcSEcCtD
Celecoxib—Urticaria—Conjugated Estrogens—osteoporosis	4.82e-05	0.000311	CcSEcCtD
Celecoxib—Dizziness—Risedronate—osteoporosis	4.8e-05	0.00031	CcSEcCtD
Celecoxib—Abdominal pain—Conjugated Estrogens—osteoporosis	4.8e-05	0.00031	CcSEcCtD
Celecoxib—Body temperature increased—Conjugated Estrogens—osteoporosis	4.8e-05	0.00031	CcSEcCtD
Celecoxib—Shock—Estradiol—osteoporosis	4.78e-05	0.000308	CcSEcCtD
Celecoxib—Nervous system disorder—Estradiol—osteoporosis	4.76e-05	0.000307	CcSEcCtD
Celecoxib—Tachycardia—Estradiol—osteoporosis	4.74e-05	0.000306	CcSEcCtD
Celecoxib—Vomiting—Ethinyl Estradiol—osteoporosis	4.73e-05	0.000306	CcSEcCtD
Celecoxib—Diarrhoea—Pamidronate—osteoporosis	4.72e-05	0.000305	CcSEcCtD
Celecoxib—Skin disorder—Estradiol—osteoporosis	4.72e-05	0.000305	CcSEcCtD
Celecoxib—Hyperhidrosis—Estradiol—osteoporosis	4.69e-05	0.000303	CcSEcCtD
Celecoxib—Rash—Ethinyl Estradiol—osteoporosis	4.69e-05	0.000303	CcSEcCtD
Celecoxib—Dermatitis—Ethinyl Estradiol—osteoporosis	4.69e-05	0.000303	CcSEcCtD
Celecoxib—Headache—Ethinyl Estradiol—osteoporosis	4.66e-05	0.000301	CcSEcCtD
Celecoxib—Hypersensitivity—Zoledronate—osteoporosis	4.64e-05	0.0003	CcSEcCtD
Celecoxib—Vomiting—Risedronate—osteoporosis	4.61e-05	0.000298	CcSEcCtD
Celecoxib—Rash—Risedronate—osteoporosis	4.57e-05	0.000295	CcSEcCtD
Celecoxib—Dermatitis—Risedronate—osteoporosis	4.57e-05	0.000295	CcSEcCtD
Celecoxib—Dizziness—Pamidronate—osteoporosis	4.56e-05	0.000295	CcSEcCtD
Celecoxib—Headache—Risedronate—osteoporosis	4.55e-05	0.000294	CcSEcCtD
Celecoxib—Asthenia—Zoledronate—osteoporosis	4.52e-05	0.000292	CcSEcCtD
Celecoxib—Hypersensitivity—Conjugated Estrogens—osteoporosis	4.47e-05	0.000289	CcSEcCtD
Celecoxib—Pruritus—Zoledronate—osteoporosis	4.46e-05	0.000288	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Estradiol—osteoporosis	4.42e-05	0.000286	CcSEcCtD
Celecoxib—Nausea—Ethinyl Estradiol—osteoporosis	4.42e-05	0.000285	CcSEcCtD
Celecoxib—Insomnia—Estradiol—osteoporosis	4.39e-05	0.000284	CcSEcCtD
Celecoxib—Vomiting—Pamidronate—osteoporosis	4.39e-05	0.000283	CcSEcCtD
Celecoxib—Paraesthesia—Estradiol—osteoporosis	4.36e-05	0.000282	CcSEcCtD
Celecoxib—Asthenia—Conjugated Estrogens—osteoporosis	4.35e-05	0.000281	CcSEcCtD
Celecoxib—Rash—Pamidronate—osteoporosis	4.35e-05	0.000281	CcSEcCtD
Celecoxib—Dermatitis—Pamidronate—osteoporosis	4.34e-05	0.000281	CcSEcCtD
Celecoxib—Dyspnoea—Estradiol—osteoporosis	4.33e-05	0.00028	CcSEcCtD
Celecoxib—Headache—Pamidronate—osteoporosis	4.32e-05	0.000279	CcSEcCtD
Celecoxib—Somnolence—Estradiol—osteoporosis	4.32e-05	0.000279	CcSEcCtD
Celecoxib—Diarrhoea—Zoledronate—osteoporosis	4.31e-05	0.000278	CcSEcCtD
Celecoxib—Nausea—Risedronate—osteoporosis	4.31e-05	0.000278	CcSEcCtD
Celecoxib—Pruritus—Conjugated Estrogens—osteoporosis	4.29e-05	0.000277	CcSEcCtD
Celecoxib—Dyspepsia—Estradiol—osteoporosis	4.27e-05	0.000276	CcSEcCtD
Celecoxib—Decreased appetite—Estradiol—osteoporosis	4.22e-05	0.000273	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Estradiol—osteoporosis	4.19e-05	0.000271	CcSEcCtD
Celecoxib—Fatigue—Estradiol—osteoporosis	4.19e-05	0.00027	CcSEcCtD
Celecoxib—Dizziness—Zoledronate—osteoporosis	4.17e-05	0.000269	CcSEcCtD
Celecoxib—Constipation—Estradiol—osteoporosis	4.15e-05	0.000268	CcSEcCtD
Celecoxib—Diarrhoea—Conjugated Estrogens—osteoporosis	4.15e-05	0.000268	CcSEcCtD
Celecoxib—Nausea—Pamidronate—osteoporosis	4.1e-05	0.000265	CcSEcCtD
Celecoxib—Dizziness—Conjugated Estrogens—osteoporosis	4.01e-05	0.000259	CcSEcCtD
Celecoxib—Vomiting—Zoledronate—osteoporosis	4.01e-05	0.000259	CcSEcCtD
Celecoxib—Feeling abnormal—Estradiol—osteoporosis	4e-05	0.000258	CcSEcCtD
Celecoxib—Rash—Zoledronate—osteoporosis	3.97e-05	0.000257	CcSEcCtD
Celecoxib—Gastrointestinal pain—Estradiol—osteoporosis	3.97e-05	0.000256	CcSEcCtD
Celecoxib—Dermatitis—Zoledronate—osteoporosis	3.97e-05	0.000256	CcSEcCtD
Celecoxib—Headache—Zoledronate—osteoporosis	3.95e-05	0.000255	CcSEcCtD
Celecoxib—Vomiting—Conjugated Estrogens—osteoporosis	3.86e-05	0.000249	CcSEcCtD
Celecoxib—Urticaria—Estradiol—osteoporosis	3.86e-05	0.000249	CcSEcCtD
Celecoxib—Abdominal pain—Estradiol—osteoporosis	3.84e-05	0.000248	CcSEcCtD
Celecoxib—Body temperature increased—Estradiol—osteoporosis	3.84e-05	0.000248	CcSEcCtD
Celecoxib—Rash—Conjugated Estrogens—osteoporosis	3.82e-05	0.000247	CcSEcCtD
Celecoxib—Dermatitis—Conjugated Estrogens—osteoporosis	3.82e-05	0.000247	CcSEcCtD
Celecoxib—Headache—Conjugated Estrogens—osteoporosis	3.8e-05	0.000245	CcSEcCtD
Celecoxib—Nausea—Zoledronate—osteoporosis	3.74e-05	0.000242	CcSEcCtD
Celecoxib—Nausea—Conjugated Estrogens—osteoporosis	3.6e-05	0.000233	CcSEcCtD
Celecoxib—Hypersensitivity—Estradiol—osteoporosis	3.58e-05	0.000231	CcSEcCtD
Celecoxib—Asthenia—Estradiol—osteoporosis	3.48e-05	0.000225	CcSEcCtD
Celecoxib—Pruritus—Estradiol—osteoporosis	3.43e-05	0.000222	CcSEcCtD
Celecoxib—Diarrhoea—Estradiol—osteoporosis	3.32e-05	0.000215	CcSEcCtD
Celecoxib—Dizziness—Estradiol—osteoporosis	3.21e-05	0.000207	CcSEcCtD
Celecoxib—Vomiting—Estradiol—osteoporosis	3.09e-05	0.000199	CcSEcCtD
Celecoxib—Rash—Estradiol—osteoporosis	3.06e-05	0.000198	CcSEcCtD
Celecoxib—Dermatitis—Estradiol—osteoporosis	3.06e-05	0.000198	CcSEcCtD
Celecoxib—Headache—Estradiol—osteoporosis	3.04e-05	0.000196	CcSEcCtD
Celecoxib—Nausea—Estradiol—osteoporosis	2.88e-05	0.000186	CcSEcCtD
Celecoxib—ALB—Metabolism—GPD2—osteoporosis	1.31e-05	0.000133	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.3e-05	0.000132	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ADCY5—osteoporosis	1.3e-05	0.000132	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GPX1—osteoporosis	1.29e-05	0.000131	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6R—osteoporosis	1.29e-05	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PSMA2—osteoporosis	1.29e-05	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PSMA5—osteoporosis	1.29e-05	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IRS2—osteoporosis	1.28e-05	0.00013	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PSMA2—osteoporosis	1.28e-05	0.00013	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PSMA5—osteoporosis	1.28e-05	0.00013	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TLN1—osteoporosis	1.27e-05	0.000129	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—OXCT1—osteoporosis	1.26e-05	0.000128	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CA2—osteoporosis	1.26e-05	0.000128	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IRS1—osteoporosis	1.25e-05	0.000127	CbGpPWpGaD
Celecoxib—CA12—Metabolism—POMC—osteoporosis	1.25e-05	0.000127	CbGpPWpGaD
Celecoxib—CA4—Metabolism—MTHFR—osteoporosis	1.24e-05	0.000126	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.24e-05	0.000126	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MGLL—osteoporosis	1.23e-05	0.000125	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—POMC—osteoporosis	1.21e-05	0.000123	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—POMC—osteoporosis	1.2e-05	0.000122	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ATIC—osteoporosis	1.2e-05	0.000122	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PNP—osteoporosis	1.2e-05	0.000122	CbGpPWpGaD
Celecoxib—CA2—Metabolism—MTHFR—osteoporosis	1.19e-05	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6R—osteoporosis	1.19e-05	0.000121	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6R—osteoporosis	1.18e-05	0.00012	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.16e-05	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—osteoporosis	1.16e-05	0.000118	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IRS1—osteoporosis	1.16e-05	0.000118	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	1.15e-05	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IGF1—osteoporosis	1.15e-05	0.000117	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—ESR2—osteoporosis	1.14e-05	0.000116	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PKM—osteoporosis	1.14e-05	0.000116	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—FDPS—osteoporosis	1.14e-05	0.000116	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ACP5—osteoporosis	1.14e-05	0.000116	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PKM—osteoporosis	1.13e-05	0.000115	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—FDPS—osteoporosis	1.13e-05	0.000115	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IRS1—osteoporosis	1.12e-05	0.000114	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ADCY5—osteoporosis	1.09e-05	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—P4HB—osteoporosis	1.09e-05	0.000111	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GPX1—osteoporosis	1.09e-05	0.000111	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—osteoporosis	1.09e-05	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KL—osteoporosis	1.09e-05	0.000111	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6R—osteoporosis	1.09e-05	0.000111	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PGLS—osteoporosis	1.08e-05	0.00011	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPD2—osteoporosis	1.08e-05	0.00011	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PGLS—osteoporosis	1.07e-05	0.000109	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPD2—osteoporosis	1.07e-05	0.000109	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	1.07e-05	0.000108	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—osteoporosis	1.07e-05	0.000108	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTH—osteoporosis	1.06e-05	0.000108	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ADCY5—osteoporosis	1.06e-05	0.000108	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TPI1—osteoporosis	1.06e-05	0.000108	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6R—osteoporosis	1.05e-05	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RAP1A—osteoporosis	1.05e-05	0.000106	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—IDH2—osteoporosis	1.04e-05	0.000106	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CNR2—osteoporosis	1.04e-05	0.000105	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SPP1—osteoporosis	1.03e-05	0.000104	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CA2—osteoporosis	1.02e-05	0.000104	CbGpPWpGaD
Celecoxib—ALB—Metabolism—OXCT1—osteoporosis	1.02e-05	0.000104	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NFATC1—osteoporosis	1.02e-05	0.000104	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DKK1—osteoporosis	1.01e-05	0.000103	CbGpPWpGaD
Celecoxib—CA9—Metabolism—MTHFR—osteoporosis	1.01e-05	0.000102	CbGpPWpGaD
Celecoxib—PTGS2—Disease—P4HB—osteoporosis	9.97e-06	0.000101	CbGpPWpGaD
Celecoxib—CA4—Metabolism—POMC—osteoporosis	9.96e-06	0.000101	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MGLL—osteoporosis	9.94e-06	0.000101	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ATIC—osteoporosis	9.9e-06	0.000101	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PNP—osteoporosis	9.9e-06	0.000101	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP27A1—osteoporosis	9.82e-06	9.98e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PNP—osteoporosis	9.82e-06	9.98e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ATIC—osteoporosis	9.82e-06	9.98e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GAPDH—osteoporosis	9.79e-06	9.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—WNT1—osteoporosis	9.74e-06	9.9e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.64e-06	9.79e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.62e-06	9.77e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ACP5—osteoporosis	9.55e-06	9.71e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—POMC—osteoporosis	9.54e-06	9.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGA—osteoporosis	9.48e-06	9.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.43e-06	9.59e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.37e-06	9.52e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NFATC1—osteoporosis	9.3e-06	9.45e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IRS2—osteoporosis	9.29e-06	9.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—DKK1—osteoporosis	9.23e-06	9.38e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—LEP—osteoporosis	9.09e-06	9.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—VDR—osteoporosis	9.08e-06	9.23e-05	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—osteoporosis	9.01e-06	9.16e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.98e-06	9.12e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL1B—osteoporosis	8.96e-06	9.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—WNT1—osteoporosis	8.89e-06	9.03e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TPI1—osteoporosis	8.88e-06	9.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTHLH—osteoporosis	8.81e-06	8.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—BMP2—osteoporosis	8.81e-06	8.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—osteoporosis	8.75e-06	8.9e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ESR1—osteoporosis	8.68e-06	8.82e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGA—osteoporosis	8.65e-06	8.79e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGB—osteoporosis	8.62e-06	8.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AGER—osteoporosis	8.56e-06	8.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ADCY5—osteoporosis	8.53e-06	8.67e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—IDH2—osteoporosis	8.45e-06	8.59e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—OXCT1—osteoporosis	8.42e-06	8.56e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CA2—osteoporosis	8.42e-06	8.56e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—P4HB—osteoporosis	8.35e-06	8.49e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—OXCT1—osteoporosis	8.35e-06	8.48e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CA2—osteoporosis	8.35e-06	8.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PSMA2—osteoporosis	8.32e-06	8.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PSMA5—osteoporosis	8.32e-06	8.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—osteoporosis	8.21e-06	8.34e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MGLL—osteoporosis	8.21e-06	8.34e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GAPDH—osteoporosis	8.2e-06	8.33e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MGLL—osteoporosis	8.14e-06	8.27e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IRS1—osteoporosis	8.11e-06	8.24e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—POMC—osteoporosis	8.04e-06	8.17e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—RAP1A—osteoporosis	7.98e-06	8.11e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP27A1—osteoporosis	7.95e-06	8.08e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—POMC—osteoporosis	7.92e-06	8.05e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TGFB1—osteoporosis	7.89e-06	8.01e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—POMC—osteoporosis	7.81e-06	7.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CALCA—osteoporosis	7.76e-06	7.88e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ACP5—osteoporosis	7.73e-06	7.86e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ENO1—osteoporosis	7.71e-06	7.83e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.67e-06	7.8e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.63e-06	7.76e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6R—osteoporosis	7.62e-06	7.74e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PSMA5—osteoporosis	7.59e-06	7.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PSMA2—osteoporosis	7.59e-06	7.72e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF1—osteoporosis	7.51e-06	7.63e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FDPS—osteoporosis	7.47e-06	7.59e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PKM—osteoporosis	7.47e-06	7.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IRS2—osteoporosis	7.47e-06	7.59e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.28e-06	7.4e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TPI1—osteoporosis	7.19e-06	7.3e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PGLS—osteoporosis	7.08e-06	7.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPD2—osteoporosis	7.08e-06	7.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CALCA—osteoporosis	7.08e-06	7.19e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KL—osteoporosis	7.04e-06	7.16e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—osteoporosis	7.04e-06	7.15e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—IDH2—osteoporosis	6.98e-06	7.09e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.96e-06	7.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—ESR1—osteoporosis	6.94e-06	7.05e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	6.92e-06	7.03e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—IDH2—osteoporosis	6.92e-06	7.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—osteoporosis	6.9e-06	7.02e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—P4HB—osteoporosis	6.76e-06	6.87e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GAPDH—osteoporosis	6.63e-06	6.74e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—osteoporosis	6.57e-06	6.68e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP27A1—osteoporosis	6.56e-06	6.67e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IRS1—osteoporosis	6.52e-06	6.62e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP27A1—osteoporosis	6.5e-06	6.61e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ATIC—osteoporosis	6.48e-06	6.58e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PNP—osteoporosis	6.48e-06	6.58e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—RAP1A—osteoporosis	6.46e-06	6.56e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ENO1—osteoporosis	6.45e-06	6.56e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MYC—osteoporosis	6.45e-06	6.55e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—osteoporosis	6.43e-06	6.54e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KL—osteoporosis	6.43e-06	6.53e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ACP5—osteoporosis	6.38e-06	6.49e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PSMA2—osteoporosis	6.36e-06	6.46e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PSMA5—osteoporosis	6.36e-06	6.46e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ACP5—osteoporosis	6.33e-06	6.43e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.25e-06	6.35e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6R—osteoporosis	6.12e-06	6.22e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF1—osteoporosis	5.95e-06	6.05e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TPI1—osteoporosis	5.93e-06	6.03e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TPI1—osteoporosis	5.88e-06	5.98e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—osteoporosis	5.75e-06	5.84e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.63e-06	5.72e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—P4HB—osteoporosis	5.58e-06	5.67e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—P4HB—osteoporosis	5.53e-06	5.62e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADCY5—osteoporosis	5.52e-06	5.61e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—OXCT1—osteoporosis	5.51e-06	5.6e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CA2—osteoporosis	5.51e-06	5.6e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GAPDH—osteoporosis	5.48e-06	5.56e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GAPDH—osteoporosis	5.43e-06	5.52e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MGLL—osteoporosis	5.37e-06	5.45e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SPP1—osteoporosis	5.34e-06	5.42e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—RAP1A—osteoporosis	5.33e-06	5.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—osteoporosis	5.3e-06	5.39e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—RAP1A—osteoporosis	5.29e-06	5.37e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—osteoporosis	5.25e-06	5.33e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ENO1—osteoporosis	5.22e-06	5.31e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP19A1—osteoporosis	5.16e-06	5.24e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PSMA2—osteoporosis	5.15e-06	5.23e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PSMA5—osteoporosis	5.15e-06	5.23e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ADCY5—osteoporosis	5.03e-06	5.12e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—osteoporosis	4.85e-06	4.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IRS2—osteoporosis	4.83e-06	4.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LEP—osteoporosis	4.72e-06	4.8e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—osteoporosis	4.68e-06	4.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—osteoporosis	4.66e-06	4.73e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—osteoporosis	4.63e-06	4.7e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.61e-06	4.69e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—IDH2—osteoporosis	4.56e-06	4.64e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MYC—osteoporosis	4.51e-06	4.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ESR1—osteoporosis	4.51e-06	4.58e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—osteoporosis	4.5e-06	4.58e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IRS2—osteoporosis	4.4e-06	4.48e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ENO1—osteoporosis	4.31e-06	4.38e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP27A1—osteoporosis	4.29e-06	4.36e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ENO1—osteoporosis	4.27e-06	4.34e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PSMA2—osteoporosis	4.25e-06	4.32e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PSMA5—osteoporosis	4.25e-06	4.32e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ADCY5—osteoporosis	4.22e-06	4.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IRS1—osteoporosis	4.21e-06	4.28e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PSMA2—osteoporosis	4.21e-06	4.28e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PSMA5—osteoporosis	4.21e-06	4.28e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX1—osteoporosis	4.2e-06	4.27e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP19A1—osteoporosis	4.17e-06	4.24e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ACP5—osteoporosis	4.17e-06	4.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—POMC—osteoporosis	4.06e-06	4.12e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6R—osteoporosis	3.96e-06	4.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—osteoporosis	3.9e-06	3.97e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TPI1—osteoporosis	3.88e-06	3.94e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—osteoporosis	3.88e-06	3.94e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IRS1—osteoporosis	3.84e-06	3.91e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—P4HB—osteoporosis	3.65e-06	3.71e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6R—osteoporosis	3.61e-06	3.67e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MYC—osteoporosis	3.61e-06	3.67e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GAPDH—osteoporosis	3.58e-06	3.64e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—osteoporosis	3.57e-06	3.63e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—RAP1A—osteoporosis	3.49e-06	3.54e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP19A1—osteoporosis	3.45e-06	3.5e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP19A1—osteoporosis	3.42e-06	3.47e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADCY5—osteoporosis	3.41e-06	3.47e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—osteoporosis	3.4e-06	3.45e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—osteoporosis	3.39e-06	3.45e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—osteoporosis	3.14e-06	3.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—POMC—osteoporosis	3.1e-06	3.15e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ENO1—osteoporosis	2.82e-06	2.86e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADCY5—osteoporosis	2.82e-06	2.86e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—osteoporosis	2.81e-06	2.85e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADCY5—osteoporosis	2.79e-06	2.84e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—osteoporosis	2.78e-06	2.83e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PSMA2—osteoporosis	2.78e-06	2.82e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PSMA5—osteoporosis	2.78e-06	2.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—osteoporosis	2.73e-06	2.77e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—osteoporosis	2.59e-06	2.63e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—osteoporosis	2.57e-06	2.61e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—POMC—osteoporosis	2.51e-06	2.55e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MYC—osteoporosis	2.35e-06	2.38e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—osteoporosis	2.34e-06	2.38e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.25e-06	2.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MYC—osteoporosis	2.14e-06	2.18e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—osteoporosis	2.14e-06	2.17e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—POMC—osteoporosis	2.07e-06	2.1e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—POMC—osteoporosis	2.05e-06	2.09e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADCY5—osteoporosis	1.84e-06	1.87e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—osteoporosis	1.83e-06	1.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—osteoporosis	1.76e-06	1.79e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—osteoporosis	1.69e-06	1.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—osteoporosis	1.61e-06	1.63e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—POMC—osteoporosis	1.35e-06	1.38e-05	CbGpPWpGaD
